QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AXGN

QT70AxoGen, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
44.84
+0.27+0.61%
OverviewShort InterestFilings
AXGNQT70AxoGen, Inc.·NASDAQ
OverviewShort InterestFilings
44.84+0.61%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-0.63
Insider Own7.96%
Shs Outstand53.18M
Perf Week5.85%
Market Cap2.37BForward P/E62.39EPS next Y0.72Insider Trans0.19%Shs Float-Perf Month5.04%
Enterprise Value2.31BPEG0.28EPS next Q0.09Inst Own-Short Float-Perf Quarter43.90%
Income-32470858.00P/S9.95EPS this Y178.77%Inst Trans-Short Ratio-Perf Half Y52.78%
Sales238.11MP/B9.39EPS next Y44.84%ROA-10.87%Short Interest-Perf YTD37.00%
Book/sh4.61P/C147.82EPS next 5Y24.18%ROE-20.74%52W High45.83 -2.16%Perf Year370.51%
Cash/sh1.56P/FCF265.32EPS past 3/5Y-ROIC-3.40%52W Low9.22 386.33%Perf 3Y-
Dividend Est.-EV/EBITDA-280.15Sales past 3/5Y17.41% 14.97%Gross Margin75.01%Volatility3.58% 3.36%Perf 5Y-
Dividend TTM-EV/Sales9.69EPS Y/Y TTM265.22%Oper. Margin-3.79%ATR (14)2.07Perf 10Y-
Dividend Ex-DateJan 27, 2010Quick Ratio5.33Sales Y/Y TTM27.27%Profit Margin-13.21%RSI (14)63.37Recom2.00
Dividend Gr. 3/5Y- 75.54%Current Ratio7.10EPS Q/Q-SMA207.40%Beta0.81Target Price47.00
Payout0.00%Debt/Eq0.08Sales Q/Q24.49%SMA5010.90%Rel Volume1.12Prev Close44.57
Employees451LT Debt/Eq0.50EarningsAug 04SMA20047.52%Avg Volume1.12MPrice44.84
IPO DateDec 17, 1986Option/ShortYes / YesEPS/Sales Surpr.-41.67% 5.17%Net Debt/EBITDA7.53Volume1,252,377Change0.61%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-29-26ReiteratedRaymond JamesOutperform$41 → $48
Apr-29-26ReiteratedH.C. Wainwright$39 → $50
Apr-29-26ReiteratedCanaccord GenuityBuy$45 → $50
Apr-24-26ReiteratedCanaccord GenuityBuy$40 → $45
Feb-23-26ReiteratedRaymond JamesOutperform$36 → $41
Feb-19-26InitiatedWells FargoOverweight$40
Dec-05-25ReiteratedH.C. Wainwright$26 → $39
Dec-05-25ReiteratedCanaccord GenuityBuy$27 → $37
Dec-04-25ReiteratedRaymond JamesOutperform$36
Dec-04-25ReiteratedJefferiesBuy$36
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue238225187
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A595845
Gross Profit178167142
Selling, General and Administrative Excl. Other154142117
Research and Development353328
Other Operating Expense
-200
Operating Income-9-8-3
Interest Expense1588
Unusual Expense
———
Non-Operating Income (Expense)80-2
Net Income Before Taxes-31-16-10
Income Taxes
000
Consolidated Net Income-31-16-10
Net Income From Continuing Operations-31-16-10
Net Income-31-16-10
EPS (Recurring)-0.63-0.34-0.23
EPS (Basic, Before Extraordinaries)-0.63-0.34-0.23
EPS (Diluted)-0.63-0.34-0.23
EBITDA-806
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio9.806.69—
Gross Margin74.7974.2275.94
Operating Margin-3.78-3.56-1.60
Net Margin-13.03-7.11-5.35
Shares Outstanding524644
Market Capitalization2,3321,506—
Operating Lease Expense
———
Insider Trading Volume
$49.06$46.46$43.86$41.26$38.66● Close Price0.00M2.64M5.29M7.93M10.58MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Wendell Amy McBrideDirectorMay 08 '26Sale42.601,64770,16293,826May 12 12:00 AM
Wendell Amy McBrideDirectorMay 08 '26Option Exercise14.853,29448,91695,473May 12 12:00 AM
Hartley Lindsey MarieCFOMay 07 '26Sale43.671,05145,89762,756May 08 12:00 AM
Weiler Kathy JohnsonDirectorMay 07 '26Option Exercise6.9532,688227,18227,307May 08 12:00 AM
Weiler Kathy JohnsonDirectorMay 07 '26Sale44.0916,344720,6230May 08 12:00 AM
Hartley Lindsey MarieCFOMay 07 '26Option Exercise8.2410,92690,00865,719May 08 12:00 AM
JOHNSON JOHNDirectorMay 07 '26Option Exercise7.0422,100155,58411,050May 08 12:00 AM
JOHNSON JOHNDirectorMay 07 '26Sale43.2611,050477,9680May 08 12:00 AM
Quackenbush DorisSales VPMay 07 '26Sale43.513,878168,72092,416May 08 12:00 AM
Kemp JensChief Marketing OfficerMay 07 '26Sale43.444,000173,76172,451May 08 12:00 AM
Hartley Lindsey MarieCFOMar 16 '26Option Exercise0.0018,000062,702Mar 18 12:00 AM
DeVinney Erick WayneChief Innovation OfficerMar 16 '26Option Exercise0.0035,8760268,002Mar 18 12:00 AM
DeVinney Erick WayneChief Innovation OfficerMar 16 '26Sale32.845,221171,458262,781Mar 18 12:00 AM
Began Marc AEVP & General CounselMar 01 '26Option Exercise0.0022,500054,562Mar 02 12:00 AM
Wendell Amy McBrideDirectorDec 16 '25Option Exercise6.9187,368603,926137,510Dec 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR